clarithromycin has been researched along with 1-hydroxymethylmidazolam in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, ZN; Hu, ZY; Li, XM; Luo, X | 1 |
| Chalasani, N; Gorski, JC; Hall, SD; Hamman, MA; Malireddy, SR; Quinney, SK; Vuppalanchi, R | 1 |
2 trial(s) available for clarithromycin and 1-hydroxymethylmidazolam
| Article | Year |
|---|---|
Evaluation of CYP3A activity in humans using three different parameters based on endogenous cortisol metabolism.
Topics: Clarithromycin; Cross-Over Studies; Cytochrome P-450 CYP3A; Female; Humans; Hydrocortisone; Male; Midazolam; Young Adult | 2009 |
Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin.
Topics: Administration, Oral; Adult; Analysis of Variance; Biopsy; Biotransformation; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Administration Schedule; Duodenum; Enzyme Inhibitors; Female; Genotype; Humans; Hydroxylation; Liver; Male; Midazolam; Middle Aged; Phenotype; Substrate Specificity; Young Adult | 2013 |